# US 2026/0066042 A1 · Methods and systems for high-throughput molecular analysis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0066042 A1
- Document ID: US20260066042A1
- Status: Published application
- Kind: A1
- Application number: 18/730,349
- Filed: 2023-01-30
- Published: 2026-03-05
- Earliest claimed: 2022-01-31
- Assignees: Opentrons Labworks Inc.
- Applicants: Opentrons Labworks Inc.
- Inventors: Henry H. LEE; Michael J. HAMMERLING; Jon LAURENT; Haiping HAO; Melissa HOPKINS; Cybill DEL CASTILLO; Pradeep BUGGA; Shinyoung KANG
- Web page: https://patentgrep.com/patent/US20260066042A1

## CPC

- G16B 20/50: Mutagenesis
- C12N 15/1065: {Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags}
- C12N 15/1096: {cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR}
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6851: Quantitative amplification
- C12Q 1/6869: Methods for sequencing
- G16B 30/00: ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B 20/00: ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B 25/20: Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
- G16B 30/20: Sequence assembly
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Provided herein are methods and systems for high throughput sequencing of nucleic acids for the surveillance of pathogens in a population and efficient identification of new pathogen variants of concern.

## Claims

### Claim 1

A method for reconstructing a genome of a pathogen, comprising:
determining an amplification cycle threshold (Ct) value for a plurality of ribonucleic acid (RNA) molecules isolated from a biological sample;
transporting the plurality of RNA molecules at a temperature no greater than −20° C. from a first location to a second location;
performing a reverse transcription polymerase chain reaction (RT-PCR) protocol on at least a portion of the plurality of RNA molecules to generate a plurality of complementary deoxyribonucleic acid (cDNA) molecules; and
sequencing all or a portion of the plurality of cDNA molecules at the second location to determine nucleotide sequences of the all or the portion of the plurality of cDNA molecules.

### Claim 2 (depends on 1)

The method of claim 1, wherein the plurality of cDNA molecules comprises a modified nucleic acid.

### Claim 3 (depends on 2)

The method of claim 2, wherein the sequencing comprises sequencing the modified nucleic acid at the second location to determine the nucleotide sequences.

### Claim 4 (depends on 1)

The method of claim 1, wherein performing the RT-PCR protocol comprises a one-step RT-PCR protocol.

### Claim 5 (depends on 4)

The method of claim 4, wherein an input volume of RNA for the one-step RT-PCR protocol is at least about 5 microliters.

### Claim 6 (depends on 4)

The method of claim 4, wherein an elongation temperature of the one-step RT-PCR protocol is about 60.5° C.

### Claim 7 (depends on 4)

The method of claim 4, wherein an elongation time of the one-step RT-PCR protocol is about 3 minutes.

### Claim 8 (depends on 4)

The method of claim 4, wherein performing the one-step RT-PCR protocol comprises use of an RMv1 or RMv2 primer set.

### Claim 9 (depends on 4)

The method of claim 4, wherein performing the one-step RT-PCR protocol comprises use of a primer, the primer comprising a 5′ end modification.

### Claim 10 (depends on 9)

The method of claim 9, wherein the primer is biotinylated at the 5′ end.

### Claim 11 (depends on 1)

The method of claim 1, further comprising tagmenting at least a portion of the plurality of cDNA molecules.

### Claim 12 (depends on 11)

The method of claim 11, wherein each cDNA molecule of the plurality of cDNA molecules is tagmented with polyethylene glycol (PEG).

### Claim 13 (depends on 11)

The method of claim 11, further comprising performing hybrid capture on at least a portion of the tagmented cDNA molecules.

### Claim 14 (depends on 11)

The method of claim 11, further comprising performing hybrid capture on at least a portion of the tagmented cDNA molecules derived from RNA molecules with a Ct value greater than about 27, as determined using a real-time quantitative polymerase chain reaction (RT-qPCR) assay.

### Claim 15 (depends on 1)

The method of claim 1, wherein performing the RT-PCR protocol comprises use of an exonuclease with a processivity of at least about 60 nucleotides per second.

### Claim 16 (depends on 1)

The method of claim 1, wherein performing the RT-PCR protocol comprises use of Taq polymerase, a tiling primer that is longer than an A400 primer, an A1200 primer, or combinations thereof.

### Claim 17

(canceled)

### Claim 18

(canceled)

### Claim 19 (depends on 1)

The method of claim 1, wherein the biological sample comprises a saliva sample, a blood sample, a urine sample, a cell lysate, or a tissue biopsy sample, and wherein the biological sample is obtained or derived from a subject or a patient.

### Claim 20

(canceled)

### Claim 21 (depends on 1)

The method of claim 1, further comprising storing data generated by the method in a database accessible through a communication medium, wherein the communication medium comprises a network connection, a wireless connection, an intranet connection, or an internet connection.

### Claim 22 (depends on 21)

The method of claim 21, wherein the data comprises the Ct values for the plurality of RNA molecules isolated from the biological sample or the nucleotide sequences.

### Claim 23

(canceled)

### Claim 24

A system for high-throughput nucleic acid sequencing and analysis, the system comprising:
a first analysis module configured to determine a plurality of respective amplification cycle threshold (Ct) values for each of a first plurality of nucleic acid populations;
a second analysis module configured to perform a one-step amplification protocol on a subset of the first plurality of nucleic acid populations;
a third analysis module comprising a molecular sequencer configured to determine a first plurality of nucleic acid sequences corresponding to each population of the subset of the first plurality of nucleic acid populations; and
a computer system configured to determine a rate of mutation in a pathogen based at least in part on the first plurality of nucleic acid sequences.

### Claim at position 25

-94. (canceled)
